Twenty compounds including curcuminoids and their pyrazolemodified analogues were synthesized in a two-step reaction: (i) condensation between benzaldehyde derivatives and pentane-2,4-dione and (ii) pyrazole cyclization of the 1,3-diketone group in the resulting curcuminoids with hydrazine hydrate. The synthesized compounds were assayed for in vitro anticancer activity against HepG2 cancer cell line by determining their half-maximal inhibitory concentration (IC 50). Pyrazole curcuminoid (1 a, IC 50 = 1.53 � 0.11 μM) was found to be the most potent molecule against the cancer cells. The pyrazole curcuminoids (1 a-3 a, 5 a) significantly exhibited between 2-to 23-fold higher anticancer activities when compared with their parent structures (1-3, 5). However, the class of fluorinated analogues (7-10; 7 a-10 a) displayed inactivities or activities close to those of respecting compounds (1-6; 1 a-6 a). Structure-activity relationship analysis indicated that the phenolic motif is responsible for inhibition of cell growth whereas the fluoro/methoxy substituents on the aromatic rings have insignificant contributions to inhibitory activities against HepG2.